Emily Pimblett - Jun 18, 2024 Form 4 Insider Report for Eliem Therapeutics, Inc. (ELYM)

Role: CHIEF ACCOUNTING OFFICER
Signature: /s/ William Cowles, Attorney-in-Fact
Stock symbol: ELYM
Transactions as of: Jun 18, 2024
Transactions value $: -$8,982
Form type: 4
Date filed: 6/21/2024, 02:57 PM
Previous filing: Mar 20, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELYM	Common Stock	Options Exercise		+5K			5K	Jun 18, 2024	Direct	F1
transaction	ELYM	Common Stock	Sale	-$8.98K	-1.25K	-24.9%	$7.21	3.76K	Jun 20, 2024	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELYM	Restricted Stock Units	Options Exercise	$0	-5K	-12.5%	$0.00	35K	Jun 18, 2024	Common Stock	5K		Direct	F3, F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock.
F2	The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs.
F3	Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F4	The shares subject to this RSU shall vest at a rate of 1/8th of the total number of shares on the three-month anniversary of March 18, 2024 (the "March 2024 Vesting Commencement Date") and 1/8th of the total number of shares each three-month anniversary of the March 2024 Vesting Commencement Date thereafter for so long as the Reporting Person provides continuous service to the Issuer, such that the total number of shares shall be fully vested on the two-year anniversary of the March 2024 Vesting Commencement Date.